January 4, 2018 / 5:42 PM / in 8 minutes BRIEF-Asterias Biotherapeutics Reports Milestone Targets For 2018 Reuters Staff 1 Min Read 
Jan 4 (Reuters) - Asterias Biotherapeutics Inc: 
* ASTERIAS BIOTHERAPEUTICS INC - AS OF DECEMBER 31, 2017, ASTERIASâ€™ CASH AND CASH EQUIVALENTS TOTALED APPROXIMATELY $21.6 MILLION 
* ASTERIAS BIOTHERAPEUTICS SAYS INTENDS TO CONTINUE DISCUSSIONS WITH FDA TO ACHIEVE CLEARANCE ON DESIGN OF NEXT STUDY FOR AST-OPC1 
* ASTERIAS BIOTHERAPEUTICS SAYS HAS SUFFICIENT RESOURCES TO FUND OPERATIONS THROUGH MID-2019 Source text for Eikon: Further company coverage: